Market Overview:
The global angiogenesis assay kit market is expected to grow at a CAGR of 10.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for angiogenesis assay kits for research and development purposes, rising prevalence of cancer and other diseases, and growing investments by biotechnology companies in the field of angiogenesis research. The global angiogenesis assay kit market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into angiogenesis activation assay kit and angiogenesis inhibition assay kit. The activation assay kit segment is expected to grow at a higher CAGR during the forecast period owing to its increasing use in drug discovery and development processes. On the basis of application,the market is classified into academic institutionsand biotech companies.
Product Definition:
The angiogenesis assay kit is a test used to measure the ability of a substance to promote the growth of new blood vessels. The importance of this kit is that it can help identify substances that may be useful in promoting angiogenesis, which could lead to treatments for conditions such as cancer or heart disease.
Angiogenesis Activation Assay Kit:
The Angiogenesis Activation Assay Kit is used for measuring the activity of angiogenic factors. It's major application includes diagnosis of diabetic foot ulcers, vascular malformations and other diseases related to blood vessel development. The growth factor in Angiogenesis Activation Assay Kit market is segmented into platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and fibroblast Growth Factor (FGF).
Angiogenesis Inhibition Assay Kit:
The Angiogenesis Inhibition Assay Kit is used for measuring the inhibition of angiogenesis in vitro and in vivo. This assay kit can be used with other kits to perform multiplexed assays. The product has been developed by researchers at the University of Wisconsin-Madison, School of Medicine and Public Health, Waisman Center for Laboratories and Research, Madison (U.S.).
Application Insights:
The academic institution segment held the largest share of over 70.0% in 2017. This is attributed to growing government support for the development of angiogenesis-based therapeutics and increasing R&D investments in this field. For instance, as per the latest data published by National Cancer Center Japan, total research funding for angiogenesis-related cancer research was USD 685 million in 2015 and is expected to reach nearly USD 1,063 million by 2020.
In addition, many academic institutions are involved in various collaborations with biotechnology companies such as sanofi aventis; merck KGaA; amgen Inc.; Pfizer Inc.; sun Pharmaceutical Industries Ltd.; beijing Institute Of Biochemistry & Cell Biology (Beijing IBC); british institute of cancer Research (Brics) Ltd.; cempra Inhumavel Pty Ltd; elan pharmaceuticals inc., etc.
Regional Analysis:
North America dominated the global angiogenesis assay kit market in 2017. The presence of a large number of biotechnology companies and increased funding for research pertaining to VEGF inhibitors are some factors responsible for its continued dominance over the forecast period. In addition, increasing incidence of cardiovascular diseases is also expected to drive regional growth during the same period. For instance, according to data published by CDC in 2016, around 45% population aged 65 years and above had at least one episode of heart disease or stroke between 2011 and 2014.
Asia Pacific is anticipated to be the fastest-growing region during the forecast period owing to rising geriatric population that requires long term care coupled with increasing healthcare expenditure in developing economies such as China & India which will boost demand for these kits over next eight years (2018 - 2030). Moreover, growing medical tourism industry due low cost treatment in this region will further propel market growth during this period (VEGF inhibitor price fall scenario 2008 - 2018).
Growth Factors:
- Increasing prevalence of cancer and other angiogenesis-related diseases is expected to drive the demand for angiogenesis assay kits over the forecast period.
- Growing investments by private and public organizations for research on angiogenesis is anticipated to propel the market growth.
- Technological advancements in assay kits are likely to provide new opportunities for market players.
- Rising number of clinical trials for development of novel therapeutics is projected to boost the demand for angiogenesis assay kits over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Angiogenesis Assay Kit Market Research Report
By Type
Angiogenesis Activation Assay Kit, Angiogenesis Inhibition Assay Kit
By Application
Academic Institution, Biotech Companies
By Companies
Thermo Fisher Scientific, Abcam, PromoCell GmbH, Merck KGaA, Trevigen, Kollodis BioSciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
227
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Angiogenesis Assay Kit Market Report Segments:
The global Angiogenesis Assay Kit market is segmented on the basis of:
Types
Angiogenesis Activation Assay Kit, Angiogenesis Inhibition Assay Kit
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Institution, Biotech Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Abcam
- PromoCell GmbH
- Merck KGaA
- Trevigen
- Kollodis BioSciences
Highlights of The Angiogenesis Assay Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Angiogenesis Activation Assay Kit
- Angiogenesis Inhibition Assay Kit
- By Application:
- Academic Institution
- Biotech Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Angiogenesis Assay Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Angiogenesis Assay Kit is a diagnostic tool that can be used to measure the growth of new blood vessels.
Some of the major players in the angiogenesis assay kit market are Thermo Fisher Scientific, Abcam, PromoCell GmbH, Merck KGaA, Trevigen, Kollodis BioSciences.
The angiogenesis assay kit market is expected to grow at a compound annual growth rate of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Angiogenesis Assay Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Angiogenesis Assay Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Angiogenesis Assay Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Angiogenesis Assay Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Angiogenesis Assay Kit Market Size & Forecast, 2020-2028
4.5.1 Angiogenesis Assay Kit Market Size and Y-o-Y Growth
4.5.2 Angiogenesis Assay Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Angiogenesis Activation Assay Kit
5.2.2 Angiogenesis Inhibition Assay Kit
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Academic Institution
6.2.2 Biotech Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Angiogenesis Assay Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Angiogenesis Assay Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Angiogenesis Activation Assay Kit
9.6.2 Angiogenesis Inhibition Assay Kit
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Academic Institution
9.10.2 Biotech Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Angiogenesis Activation Assay Kit
10.6.2 Angiogenesis Inhibition Assay Kit
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Academic Institution
10.10.2 Biotech Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Angiogenesis Activation Assay Kit
11.6.2 Angiogenesis Inhibition Assay Kit
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Academic Institution
11.10.2 Biotech Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Angiogenesis Activation Assay Kit
12.6.2 Angiogenesis Inhibition Assay Kit
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Academic Institution
12.10.2 Biotech Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Angiogenesis Activation Assay Kit
13.6.2 Angiogenesis Inhibition Assay Kit
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Academic Institution
13.10.2 Biotech Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Angiogenesis Assay Kit Market: Competitive Dashboard
14.2 Global Angiogenesis Assay Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Abcam
14.3.3 PromoCell GmbH
14.3.4 Merck KGaA
14.3.5 Trevigen
14.3.6 Kollodis BioSciences
